BCAP31 and lung carcinoma: Because of the high antigenicity and immunogenicity of CTAs, several of them, such as the MAGE-A family, BCAP31, and the LY6 family, have been considered as biomarkers for lung cancer diagnosis and prognostic prediction (21–23).